Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 4
1(100.0%)
1Total
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT04311099Phase 4Completed

Optimal Peripheral Nerve Block After Minimally Invasive Colon Surgery

Role: lead

NCT06287671Recruiting

Colorectal Omics and OfCS Proteoglycans

Role: lead

NCT04477824Completed

Is Acute Appendicitis Still a Clinical Diagnosis?

Role: lead

NCT04407117Completed

Appendicitis During the National Lockdown During the COVID-19 Pandemic

Role: lead

NCT04395534Completed

Non-microradical Resection Margin as a Predictor for Recurrence After Complete Mesocolic Excision

Role: lead

All 5 trials loaded